Date published: 2025-12-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ROPN1 Inhibitors

ROPN1 inhibitors belong to a class of chemical compounds that modulate the function of the ROPN1 (Ropporin 1A) protein. ROPN1 is a protein found in various cell types, playing pivotal roles in cellular processes that are not fully elucidated but are believed to involve the regulation of cell signaling, particularly in cilia and flagella. It's important to understand that the structure and function of proteins like ROPN1 can be influenced by various molecules, and inhibitors are specifically designed or identified to reduce or block the function of their target protein.

Chemically, ROPN1 inhibitors can be of diverse structures, often dependent on the specific site of the ROPN1 protein they target. The molecular interaction between an inhibitor and ROPN1 can be due to various types of chemical bonds, including hydrogen bonds, van der Waals forces, ionic bonds, and covalent bonds. The specificity and affinity of an inhibitor for ROPN1 largely determine its potency. It's also worth noting that the development of ROPN1 inhibitors, like other types of inhibitors, involves a rigorous process of chemical synthesis and biological evaluation. Computational tools, crystallography, and various biochemical assays are employed to understand the binding mechanism, validate the inhibitory effect, and ensure specificity towards ROPN1 without affecting other unrelated cellular processes. As with any chemical class, the safety, solubility, and stability of these compounds are of paramount importance and are evaluated extensively during the development and characterization stages.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Zanubrutinib

1691249-45-2sc-507434
5 mg
$360.00
(0)

Binds irreversibly to the cysteine-481 residue of Bruton's tyrosine kinase, inhibiting B-cell receptor signaling in B-cell malignancies.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$116.00
$330.00
$510.00
$816.00
$1632.00
10
(0)

Selectively inhibits B-cell lymphoma-2 (BCL-2) to promote apoptosis in cancer cells, particularly effective in chronic lymphocytic leukemia (CLL).

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

Covalently binds to the cysteine-481 residue of Bruton's tyrosine kinase (BTK), disrupting B-cell receptor signaling in B-cell malignancies.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$240.00
$1030.00
7
(1)

Competitively inhibits androgen receptor (AR) signaling by binding to AR and blocking its activation, used in prostate cancer therapy.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Inhibits the tyrosine kinase activity of BCR-ABL fusion protein in chronic myeloid leukemia (CML) cells, blocking the proliferation of leukemic cells.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Targets the epidermal growth factor receptor (EGFR) tyrosine kinase, hindering cell growth in EGFR-mutated lung cancer by inhibiting downstream signaling pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Inhibits multiple kinases, including RAF kinases and VEGFR, to block angiogenesis and cell proliferation in various cancer types, particularly hepatocellular carcinoma.

Rucaparib

283173-50-2sc-507419
5 mg
$150.00
(0)

PARP inhibitor that disrupts DNA repair in BRCA-mutated cancer cells, leading to genomic instability and cell death.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

PARP inhibitor that interferes with DNA repair mechanisms in BRCA-mutated tumor cells, causing synthetic lethality and apoptosis.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

Cyclin-dependent kinase (CDK) 4/6 inhibitor, halting cell cycle progression in hormone receptor-positive breast cancer by blocking the phosphorylation of retinoblastoma protein.